Literature DB >> 22957741

Importance of direct macrophage-tumor cell interaction on progression of human glioma.

Yoshihiro Komohara1, Hasita Horlad, Koji Ohnishi, Yukio Fujiwara, Bing Bai, Takenobu Nakagawa, Shinya Suzu, Hideo Nakamura, Jun-ichi Kuratsu, Motohiro Takeya.   

Abstract

We previously showed tumor-associated macrophages/microglia (TAMs) polarized to the M2 phenotype were significantly involved in tumor cell proliferation and poor clinical prognosis in patients with high grade gliomas. However, the detailed molecular mechanisms involved in the interaction between TAMs and tumor cells have been unclear. Current results reveal that, in coculture with human macrophages, BrdU incorporation was significantly elevated in glioma cells, and signal transducer and activator of transcription-3 (Stat3) activation was found in both cell types. Direct mixed coculture led to stronger Stat3 activation in tumor cells than did indirect separate coculture in Transwell chamber dishes. Screening with an array kit for phospho-receptor tyrosine kinases revealed that phosphorylation of macrophage-colony stimulating factor receptor (M-CSFR, CD115, or c-fms) is possibly involved in this cell-cell interaction; M-CSFR activation was detected in both cell types. Coculture-induced tumor cell activation was suppressed by siRNA-mediated downregulation of the M-CSFR in macrophages and by an inhibitor of M-CSFR (GW2580). Immunohistochemical analysis of phosphorylated (p)M-CSFR, pStat3, M-CSF, M2 ratio, and MIB-1(%) in high grade gliomas revealed that higher staining of pM-CSFR in tumor cells was significantly associated with higher M-CSF expression and higher MIB-1(%). Higher staining of pStat3 was associated with higher MIB-1(%). High M2 ratios were closely correlated with high MIB-1(%) and poor clinical prognosis. Targeting these molecules or deactivating M2 macrophages might be useful therapeutic strategies for high grade glioma patients.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22957741     DOI: 10.1111/cas.12015

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  49 in total

1.  The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients' survival.

Authors:  Maya Gulubova; Julian Ananiev; Yovchev Yovchev; Aleksander Julianov; Anatoli Karashmalakov; Tatyana Vlaykova
Journal:  J Mol Histol       Date:  2013-06-26       Impact factor: 2.611

Review 2.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

3.  CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages.

Authors:  Ishani De; Megan D Steffen; Paul A Clark; Clayton J Patros; Emily Sokn; Stephanie M Bishop; Suzanne Litscher; Vilena I Maklakova; John S Kuo; Fausto J Rodriguez; Lara S Collier
Journal:  Cancer Res       Date:  2016-03-24       Impact factor: 12.701

4.  Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin.

Authors:  Sophie A Dusoswa; Jan Verhoeff; Erik Abels; Santiago P Méndez-Huergo; Diego O Croci; Lisan H Kuijper; Elena de Miguel; Valerie M C J Wouters; Myron G Best; Ernesto Rodriguez; Lenneke A M Cornelissen; Sandra J van Vliet; Pieter Wesseling; Xandra O Breakefield; David P Noske; Thomas Würdinger; Marike L D Broekman; Gabriel A Rabinovich; Yvette van Kooyk; Juan J Garcia-Vallejo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

Review 5.  Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.

Authors:  Aitziber Buqué; Norma Bloy; Fernando Aranda; Isabelle Cremer; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

6.  Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma.

Authors:  Susan Brandenburg; Kati Turkowski; Annett Mueller; Yordan T Radev; Sabine Seidlitz; Peter Vajkoczy
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

7.  Selective depletion of cultured macrophages by magnetite nanoparticles modified with gelatin.

Authors:  Yoshihiro Komohara; Ryuta Kawauchi; Erika Makiyama; Kazuki Mikami; Hasita Horlad; Yukio Fujiwara; Tetsuya Kida; Motohiro Takeya; Takuro Niidome
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

8.  MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.

Authors:  A Ghoochani; M A Schwarz; E Yakubov; T Engelhorn; A Doerfler; M Buchfelder; R Bucala; N E Savaskan; I Y Eyüpoglu
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

Review 9.  Immunotherapy of Primary Brain Tumors: Facts and Hopes.

Authors:  Robin A Buerki; Zinal S Chheda; Hideho Okada
Journal:  Clin Cancer Res       Date:  2018-06-05       Impact factor: 12.531

10.  Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.

Authors:  Isaac Almendros; Yang Wang; Lev Becker; Frances E Lennon; Jiamao Zheng; Brittney R Coats; Kelly S Schoenfelt; Alba Carreras; Fahed Hakim; Shelley X Zhang; Ramon Farré; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.